NEUROCHEMICAL ASSESSMENT AND BEHAVIORAL ROLE OF TUBEROINFUNDIBULAR PEPTIDE-39 IN ACUTE RESTRAINT STRESS-INDUCED DEPRESSION IN RATS.
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i1.21723Keywords:
Tuberoinfundibular peptide of 39, Acute restraint stress, Hypothalamic-pituitary-adrenal axis, Glutamate, Gamma-aminobutyric acid, NoradrenalineAbstract
 Objective: Tuberoinfundibular peptide of 39 (TIP39) is a potent agonist to the parathyroid hormone 2 receptor (PTH2R) abundantly expressed in brain. The current study focused to evaluate the role of TIP39 in acute restraint stress (ARS)-induced depression model.
Methods: Rats were exposed to ARS for 2 h to establish the depression and then subjected to open field and forced swim test (OFT and FST). TIP39 (1 and 10 nmol/rat) and HYWH (1 nmol/rat) are a PTH2R antagonist which was infused through intracerebroventricular route. Diazepam (2 mg/kg, i.p) was utilized as reference standard.
Results: The results depict ARS significantly diminished the TIP39 expression in cerebral regions and causes depression-like behavior. TIP39 significantly decreased the immobility period in FST. In the OFT, TIP39 significantly increased the ambulatory activity and did not alter the rearing and grooming activity in comparison to ARS group. After TIP39 treatment, plasma noradrenaline levels were significantly increased, whereas the serotonin levels were unaltered. The corticosterone levels also decreased significantly. In rat brain tissues, TIP39 significantly reversed the abnormalities in glutamate and gamma-aminobutyric acid (GABA) level by ARS induction. In contrast, HYWH-treated rats did not show any significant variations in the neurochemical and behavioral parameters in comparison to ARS rats.
Conclusion: Our reports submitted that the primary evidence depicting the stimulation of TIP39 expression could modulate the monoaminergic, GABAergic, and glutaminergic release with the support of hypothalamic-pituitary-adrenal axis that can be produced an antidepressant-like effect evident with the interactive study.
Downloads
References
Budni J, Zomkowski AD, Engel D, Santos DB, dos Santos AA, Moretti M, et al. Folic acid prevents depressive-like behavior and hippocampal antioxidant imbalance induced by restraint stress in mice. Exp Neurol 2013;240:112-21.
Santosh P, Venugopl R, Nilakasha S, Kunjbihari S, Mangala L. Antidepressant activity of methanolic extract of Passiflora foetida leaves in mice. Int J Pharm Pharm Sci 2011;3:6-9.
LaBuda CJ, Dobolyi A, Usdin TB. Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions. Neuroreport 2004;15:881-5.
Coutellier L, Usdin TB. Enhanced long-term fear memory and increased anxiety and depression-like behavior after exposure to an aversive event in mice lacking TIP39 signaling. Behav Brain Res 2011;222:265-9.
Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, et al. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Res 2007;155:245-56.
Barden N. Implication of the hypothalamic-pituitary-adrenal axis in the physiopathology of depression. J Psychiatry Neurosci 2004;29:185-93.
Nikisch G. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett 2009;30:11-6.
Catena-Dell’Osso M, Fagiolini A, Rotella F, Baroni S, Marazziti D. Glutamate system as target for development of novel antidepressants. CNS Spectr 2013;18:188-98.
Mathew SJ, Keegan K, Smith L. Glutamate modulators as novel interventions for mood disorders. Rev Bras Psiquiatr 2005;27:243-8.
Hashimoto K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 2009;61:105-23.
Santos GA, Pereira VD, Roman EA, Ignacio-Souza L, Vitorino DC, de Moura RF, et al. Hypothalamic inhibition of acetyl-coA carboxylase stimulates hepatic counter-regulatory response independent of AMPK activation in rats. PLoS One 2013;8:e62669.
Pawar DB, Marathe PA, Rege NN. Antidepressant activity of aqueous extracts of fruits of Terminalia chebula and Phyllanthus emblica in behavioral models of depression: Involvement of monoaminergic system. Int J Pharm Pharm Sci 2014;6:615-20.
Devi1 T, Das S. Evaluation of the protective effect of ethanolic extract of leaves of Punica granatum linn. On forced swimming induced chronic fatigue syndrome in mice. Int J Pharm Pharm Sci 2017;9:207-12.
Parrot S, Neuzeret PC, Denoroy L. A rapid and sensitive method for the analysis of brain monoamine neurotransmitters using ultra-fast liquid chromatography coupled to electrochemical detection. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:3871-8.
Tshibangu DS, Divakar S, Ramanathan M, Syamala GG, Ngbolua K, Mudogo V, et al. In vitro Screening of the leaf extracts from Gardenia ternifolia (Forest Gardenia) for their Anticancer Activity. J Complement Alternat Med 2016;1:1-7.
Badenhorst NJ, Brand L, Harvey BH, Ellis SM, Brink CB. Long-term effects of pre-pubertal fluoxetine on behaviour and monoaminergic stress response in stress-sensitive rats. Acta Neuropsychiatr 2017;29:222-35.
Darshit BS, Ramanathan M. Activation of AKT1/GSK-3??/??-Catenin???TRIM11/Survivin Pathway by Novel GSK-3?? Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model. Mol Neurobiol 2016;53:6716-29.
Subakanmani S, Umadevi P. Evaluation of anxiolytic potential of ethanolic extract Hypericum hookerianum in stress induced swiss albino mice. Int Res J Pharm 2012;3:219-25.
Paul IA, Skolnick P. Glutamate and Depression: Clinical and Preclinical Studies. Ann N Y Acad Sci 2003;1003:250-72.
Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985;85:367-70.
Joca SR, Padovan CM, Guimarães FS. Activation of post-synaptic 5-HT1A receptors in the dorsal hippocampus prevents learned helplessness development. Brain Res 2003;978:177-84.
Freitas AE, Egea J, Buendia I, Gómez-Rangel V, Parada E, Navarro E, et al. Agmatine, by improving neuroplasticity markers and inducing nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol Neurobiol 2016;53:3030-45.
Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009;10:397-409.
Dobolyi A, Palkovits M, Usdin TB. Expression and distribution of tuberoinfundibular peptide of 39 residues in the rat central nervous system. J Comp Neurol 2003;455:547-66.
Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 2008;69 Suppl E1:4-7.
Coutellier L, Logemann A, Kuo J, Rusnak M, Usdin TB. TIP39 modulates effects of novelty-induced arousal on memory. Genes Brain Behav 2011;10:90-9.
Mathews DC, Henter ID, Zarate CA. Targeting the glutamatergic system to treat major depressive disorder: Rationale and progress to date. Drugs 2012;72:1313-33.
Dimitrov EL, Kim YY, Usdin TB. Regulation of hypothalamic signaling by tuberoinfundibular peptide of 39 residues is critical for the response to cold: A novel peptidergic mechanism of thermoregulation. J Neurosci 2011;31:18166-79.
Wang T, Palkovits M, Rusnak M, Mezey E, Usdin TB. Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience 2000;100:629-49.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
